Table 3.
Evolution for secondary outcomes from baseline to 24 months of follow-up Incidence for categorical outcomes is shown
| Characteristics | Control (n = 98) | Intervention (n = 127) | p-value |
|---|---|---|---|
| Anaemia | 13% (6; 22) | 11% (6; 18) | 0.87 |
| Barthel index * | −7.30 (−11.0; −3.7) | −8.40 (−11.3; −5.5) | 0.66 |
| Lawton index* | −0.58 ( −0.95; -0.21) | −1.20 (−1.53; -0.88) | 0.01 |
| Hospital emergencies | 30% (20; 42) | 23% (15; 32) | 0.36 |
| Hospital admissions | 13% (7; 22) | 18% (11; 26) | 0.50 |
| Haemoglobin, g/L* | −0.61 (−0.92; −0.30) | −0.26 (−0,44; −0.08) | 0.05 |
| Albumin, (normal range 35.0-53.0 g/L)* | −1.30(−1.92; −0.75) | −0.91 (−1.4; −0.42) | 0.26 |
| Ferritin, (normal range 21.8-274.7 μg/L)* | −2.83 (−15.5; 9.88) | 10.46 (−1.70; 22.6) | 0.13 |
The mean difference between 24 months follow-up and baseline for each intervention group is also shown for quantitative variables. For every estimation the 95% confidence interval is also estimated.
*Negative mean differences indicate a decline in the MNA score.